These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 38056703

  • 21. Effective amelioration of the Lucio phenomenon with adjuvant tofacitinib therapy in a patient with dual infection of Mycobacterium leprae and Mycobacterium lepromatosis: a case report from India.
    Patel NH, Padhiyar JK, Patel KA, Patel JR, Lakum MP, Singh I.
    Access Microbiol; 2023; 5(10):. PubMed ID: 37970083
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Mutations in the drug resistance-determining region of Mycobacterium lepromatosis isolated from leprosy patients in Mexico.
    Kai M, Fafutis-Morris M, Miyamoto Y, Mukai T, Mayorga-Rodriguez J, Rodriguez-Castellanos MA, Martínez-Guzman MA, Matsuoka M.
    J Dermatol; 2016 Nov; 43(11):1345-1349. PubMed ID: 27345334
    [Abstract] [Full Text] [Related]

  • 25. A new Mycobacterium species causing diffuse lepromatous leprosy.
    Han XY, Seo YH, Sizer KC, Schoberle T, May GS, Spencer JS, Li W, Nair RG.
    Am J Clin Pathol; 2008 Dec; 130(6):856-64. PubMed ID: 19019760
    [Abstract] [Full Text] [Related]

  • 26. Survival of Mycobacterium leprae and association with Acanthamoeba from environmental samples in the inhabitant areas of active leprosy cases: A cross sectional study from endemic pockets of Purulia, West Bengal.
    Turankar RP, Lavania M, Darlong J, Siva Sai KSR, Sengupta U, Jadhav RS.
    Infect Genet Evol; 2019 Aug; 72():199-204. PubMed ID: 30658215
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Selective decrease of M. leprae-specific IgG1 and IgG3 antibodies in leprosy patients associated with ENL.
    Kifayet A, Hussain R.
    Int J Lepr Other Mycobact Dis; 1996 Jun; 64(2):105-14. PubMed ID: 8690967
    [Abstract] [Full Text] [Related]

  • 32. Ofloxacin resistance in multibacillary new leprosy cases from Purulia, West Bengal: a threat to effective secondary line treatment for rifampicin-resistant leprosy cases.
    Ahuja M, Singh I, Lavania M, Pathak VK, Darlong J, Turankar RP, Hembrom S, Singh SV, Sengupta U.
    J Glob Antimicrob Resist; 2022 Sep; 30():282-285. PubMed ID: 35717020
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Differential immunoglobulin and complement levels in leprosy prior to development of reversal reaction and erythema nodosum leprosum.
    Amorim FM, Nobre ML, Nascimento LS, Miranda AM, Monteiro GRG, Freire-Neto FP, Queiroz MDCP, Queiroz JW, Duthie MS, Costa MR, Reed SG, Johnson WD, Dupnik KM, Jeronimo SMB.
    PLoS Negl Trop Dis; 2019 Jan; 13(1):e0007089. PubMed ID: 30689631
    [Abstract] [Full Text] [Related]

  • 35. Presence of viable Mycobacterium leprae in environmental specimens around houses of leprosy patients.
    Turankar RP, Lavania M, Singh M, Sengupta U, Siva Sai K, Jadhav RS.
    Indian J Med Microbiol; 2016 Jan; 34(3):315-21. PubMed ID: 27514953
    [Abstract] [Full Text] [Related]

  • 36. Household costs of leprosy reactions (ENL) in rural India.
    Chandler DJ, Hansen KS, Mahato B, Darlong J, John A, Lockwood DN.
    PLoS Negl Trop Dis; 2015 Jan; 9(1):e0003431. PubMed ID: 25590638
    [Abstract] [Full Text] [Related]

  • 37. Case of diffuse lepromatous leprosy associated with "Mycobacterium lepromatosis".
    Vera-Cabrera L, Escalante-Fuentes WG, Gomez-Flores M, Ocampo-Candiani J, Busso P, Singh P, Cole ST.
    J Clin Microbiol; 2011 Dec; 49(12):4366-8. PubMed ID: 22012006
    [Abstract] [Full Text] [Related]

  • 38. Clinical and histologic variations among thirty patients with Lucio's phenomenon and pure and primitive diffuse lepromatosis (Latapi's lepromatosis).
    Rea TH, Jerskey RS.
    Int J Lepr Other Mycobact Dis; 2005 Sep; 73(3):169-88. PubMed ID: 16830639
    [Abstract] [Full Text] [Related]

  • 39. Molecular mimicry between HSP 65 of Mycobacterium leprae and cytokeratin 10 of the host keratin; role in pathogenesis of leprosy.
    Singh I, Yadav AR, Mohanty KK, Katoch K, Bisht D, Sharma P, Sharma B, Gupta UD, Sengupta U.
    Cell Immunol; 2012 Sep; 278(1-2):63-75. PubMed ID: 23121977
    [Abstract] [Full Text] [Related]

  • 40. Diffuse Lepromatous Leprosy Due to Mycobacterium lepromatosis in Quintana Roo, Mexico.
    Han XY, Quintanilla M.
    J Clin Microbiol; 2015 Nov; 53(11):3695-8. PubMed ID: 26311856
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.